Pharmacy Benefit Manager Legislation and the Impact on the Pharma Supply Chain
December 19, 2024

Pharmacy Benefit Manager Legislation and the Impact on the Pharma Supply Chain

The Cost of PBMs Last week, Senator Elizabeth Warren (D-Massachusetts) and Josh Hawley (R-Missouri) introduced a bill requiring healthcare companies that own health insurers or pharmacy benefit managers (PBMs) to sell pharmacy assets within three years. If this legislation were to pass, it would significantly impact the pharmaceutical supply chain and perhaps help to control […]
Read More
Trump’s Tariffs and Drug Prices
December 11, 2024

Trump’s Tariffs and Drug Prices

Following his election victory, president-elect Donald Trump announced intentions of implementing tariffs on Canada, Mexico, and China; these tariffs include 25% tax on imports from both Mexico and Canada, and an additional 10% increase on the tariffs already in place on Chinese exports to the United States. The goals of these imports, according to the […]
Read More
What Isn’t Included in the Recent Exemption
November 27, 2024

What Isn’t Included in the Recent Exemption

Who Does It Apply To? Recently, I shared that eligible trading partners were temporarily exempted from specific components of the Drug Supply Chain Security Act, “Latest DSCSA Exemption”. However, considering the stabilization period ends tomorrow, I thought I’d share some further insights on what isn’t part of the recent exemption. First, as noted in my […]
Read More
So, You Think You’re Exempt
November 22, 2024

So, You Think You’re Exempt

DSCSA Deadline: Just Days Away The deadline for DSCSA stabilization is just days away, mandating Enhanced Drug Distribution Security (EDDS) requirements for manufacturers, repackagers, wholesale distributors, and dispensers. While the FDA announced an extension from certain components of the FD&C in the form of a phased approach, this extension only applies to certain eligible trading […]
Read More
What Is Exempt, per recent DSCSA Update 
November 22, 2024

What Is Exempt, per recent DSCSA Update 

According to the DSCSA Exemption Announcement from the FDA on October 9th, here are the specific components of the legislation that eligible trading partners are exempt from.  Section 582(g)(1)(A-F) for Manufacturers and Repackagers, Wholesale distributors, and Dispensers  ‘‘(A) The transaction information and the transaction statements as required under this section shall be exchanged in a […]
Read More